Heterogeneous intracellular expression of B‐cell receptor components in B‐cell chronic lymphocytic leukaemia (B‐CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B‐CLL‐derived cell line
- 31 August 2005
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 130 (6), 878-889
- https://doi.org/10.1111/j.1365-2141.2005.05699.x
Abstract
B-cell chronic lymphocytic leukaemia (B-CLL) cells display low amounts of surface immunoglobulins (sIg). To investigate the mechanisms underlying this phenomenon, we performed a thorough study of surface and intracellular expression of the B-cell receptor (BCR) components in B-CLL cells using flow cytometry. There was an heterogeneous pattern of expression. Overall, 20 of 22 samples showed reduced sIgM levels, compared with normal B cells. Among them, three (15%) had very low to undetectable intracellular IgM levels and variable amounts of CD79a and CD79b; nine (45%) had low intracellular CD79b levels but appreciable levels of IgM and CD79a; and eight (40%) had relatively normal intracellular levels of all BCR components. To investigate whether surface BCR levels could be controlled by the rate of CD79b synthesis, adenoviral vectors encoding CD79b were generated and used for gene transfer experiments. Delivery of CD79b to non-B cells transfected with IgM and CD79a lead to high-level expression of a functional BCR. Moreover, CD79b gene transfer in a B cell line derived from a B-CLL patient and characterised by low intracellular levels of endogenous CD79b consistently increased sIgM levels. These findings indicate that the phenotype of B-CLL cells in a subset of patients may depend primarily on poor CD79b expression, and suggest that upregulation of CD79b expression may correct the phenotype of these cells.This publication has 29 references indexed in Scilit:
- Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the μ and CD79a chainsBlood, 2005
- Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein–Barr virus reactivationLeukemia, 2003
- The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progressionBlood, 2003
- Defective assembly of the B-cell receptor chains accounts for its low expression in B-chronic lymphocytic leukaemiaBritish Journal of Haematology, 2002
- Autologous Antileukemic Immune Response Induced by Chronic Lymphocytic Leukemia B Cells Expressing the CD40 Ligand and Interleukin 2 TransgenesHuman Gene Therapy, 2001
- Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cellsGene Therapy, 1997
- Enhanced: Antigen Presentation by Memory B Cells--The Sting Is in the TailScience, 1997
- Aberrant B Cell Development and Immune Response in Mice with a Compromised BCR ComplexScience, 1996
- Structure and Function of the B Cell Antigen ReceptorAnnual Review of Cell Biology, 1993
- Molecular components of the B-cell antigen receptor complex of the IgM classNature, 1990